US 7691895
Thrombopoietin activity modulating compounds and methods
granted A61PA61P21/04A61P25/00
Quick answer
US patent 7691895 (Thrombopoietin activity modulating compounds and methods) held by Ligand Pharmaceuticals Incorporated expires Mon Apr 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ligand Pharmaceuticals Incorporated
- Grant date
- Tue Apr 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61P, A61P21/04, A61P25/00, A61P43/00, A61P7/00